Tilray Brands, Inc. (TLRY) Dips More Than Broader Market: What You Should Know

Company Performance - Tilray Brands, Inc. (TLRY) closed at $9.02, reflecting a -2.59% change from the previous day's closing price, underperforming the S&P 500 which lost 0.14% [1] - Over the past month, Tilray's shares have appreciated by 18.35%, outperforming the Medical sector's loss of 0.56% and the S&P 500's gain of 0.94% [1] Upcoming Earnings - The upcoming earnings report for Tilray Brands, Inc. is scheduled for January 8, 2026, with analysts expecting earnings of -$0.14 per share, indicating year-over-year growth of 86% [2] - The consensus estimate for quarterly revenue is $209.65 million, which represents a decrease of 0.62% from the same period last year [2] Full Year Estimates - For the full year, analysts expect earnings of -$0.25 per share and revenue of $866.74 million, reflecting changes of -350% and +5.53% respectively from the previous year [3] Analyst Estimates - Recent changes to analyst estimates for Tilray Brands, Inc. are important as they indicate shifts in near-term business trends, with positive revisions suggesting analyst optimism about the company's profitability [4] - The Zacks Rank system, which incorporates these estimate changes, provides a rating system that has historically outperformed, with 1 stocks yielding an average annual gain of +25% since 1988 [5][6] Industry Context - The Medical - Products industry, part of the Medical sector, currently holds a Zacks Industry Rank of 196, placing it in the bottom 21% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]